R2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHL

Clinical trial NCT04152577 · UNKNOWN

Trial details

NCT number: NCT04152577
Sponsor: Shandong Provincial Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2019-06-05
Primary completion: 2021-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.